Friday, February 3, 2012

Could this be the start to our ‘silent genocide’ with former VP of Monsanto as Food Safety Czar promoted to Senior Advisor to the Commissioner of the FDA?


Monsanto has a somewhat Good and Really Bad track record and history so far over the years, and now they  promote the former VP/Lobbyist who was in charge of the nations Food Safety for the FDA.  Sounds like a warning of only more sickness,  disease, and death which is a sort of silent genocide?  
I say that because I truly don’t think they want the aware citizens of  the  United States to pick up arms and start fighting back.  What better way to do it then our source of survival , because we all have to eat food and drink water, milk and  while we are making new friendships and bonds online everyone has become so disenfranchised with each other as to one on one/group contact in the flesh  for various  reasons.
Plus Bill Gates is lining Monsanto’s  pockets with a $20 million dollar donation from the Bill and Melinda Gates Foundation to push more GMO food our way.   shera~


Monsanto Investor Bill Gates Says GMO Crops Needed to Fight Starvation

Bill Gates, the heavy Monsanto investor who purchased 500,000 shares of the biotech giant in 2010, has been touting Monsanto’s genetically modified creations as a tool that is necessary to prevent starvation in poor nations. The same poor nations where thousands of farmers routinely commit suicide after being completely bankrupt by Monsanto’s overpriced and ineffective GM seeds. The samecompany that we recently exposed to be running ‘slave-like’ working conditions, forcing poor workers to operate the corn fields for 14 hours per day while withholding pay.

Why is a Monsanto lobbyist serving as the FDA’s Food Safety Czar?

 thank you Gregory


Why is a former Monsanto lobbyist currently serving as the FDA’s food safety czar waging war on small dairy farms that produce fresh milk?  While factory farm operators are getting away with serious food safety violations, raw milk dairy farmers and distributors across the country have been subjected to armed raids and hauled away in handcuffs. 
President Obama has appointed the former Monsanto Vice President and lobbyist Michael R. Taylor to the throne. This is thesame manwho was Food Safety Czar for the FDA when Genetically Modified Organisms were allowed into the US food supply without undergoing a single test to determine their safety or risks.This is like putting a terrorist in charge of the world’s food supply. What will the cancer numbers look like in 2016?
The GMO nightmare all started with the Dan Quayle led FDA/GMO marriage. Under George Bush Senior’s Administration from 1989 to 1993, Dan Quayle single-handedly catapulted GMO’s into existence through FDA’s anti-consumer right-to-know policy, which stated that GMO foods did not have to be labeled or safety tested. Yes, you read that correctly: There isno safety testing requiredwhatsoever to take someAgent Orangepesticide and genetically mutate the seeds of vegetables in a chemical laboratory so that nothing on planet earth will eat the plant that grows from the groundexcept for all the humanswho have no idea what happened.
(NaturalNews) Those still in denial about the connection between the so-called “humanitarian” efforts of the Bill & Melinda Gates Foundation, and the bigger agenda to thrust genetically-modified organisms (GMOs) on the populations of the world (among other things), need look no further than the Golden Rice Project (GRP) for proof that things are not as they seem. Hailed as the solution to “micronutrient deficiencies in developing countries,” GRP is actually nothing more than an attempted Trojan horse to usherGMOsinto countries that have thus far rejected them.
According to a recent story published byFood Consumer, the Bill & Melinda Gates Foundation has donated $20 million to develop “goldenrice,” a type of GM rice that allegedly contains higher than normal levels ofvitamin A. Monsanto, creator of this “Frankenrice,” claims the crop will help end the epidemic of vitamin A deficiency (VAD) that afflicts many living in poor Asian countries. Sounds great, right? Except for the fact that introducing the rice threatens to actually worsen the VAD crisis, and promote economic and ecological debacles of epic proportions.
“Golden rice is a Trojan horse for pushing through GE-friendly biosafety regulations under the guise of humanitarian aid,” reportsFood Freedom.

Bayer CropScience and Monsanto Reach Agreement Providing Farmers Broader Access to Patented Technology

Agreement Settles Multiple Patent Disputes
Monheim (Germany) and St. Louis, Missouri (USA) 
October 14th, 2003.
Bayer CropScience AG and Monsanto Company (NYSE: MON) announced today a broad-reaching business agreement that will provide farmers worldwide greater access to the new agricultural technologies being developed by both companies. Today’s agreement dismisses several long-pending lawsuits and resolves several outstanding patent disputes between the companies.
The companies agreed to cross-license each other under their respective patent estates for herbicide tolerance and insect resistance technologies.
  • USDA to Rubber-Stamp Contamination of Food with Illegal, Genetically Engineered Rice Banned in Japan and Europe
    U.S. Dismantles Regulation of Genetically Engineered Crops to Serve Interests of Biotechnology Industry
    Press Release – Center for Food Safety, Sept. 11, 2006
The U.S. Department of Agriculture (USDA) today initiated fast-track market approval of an illegal, genetically-engineered (GE) rice variety that has contaminated long-grain rice throughout the South, throwing rice markets into turmoil and potentially causing harm to consumers and the environment. Bayer CropScience developed the rice, known as LL601.  Bayer field-tested LL601 from 1998-2001, but for unknown reasons never applied to USDA for market approval.
Though LL601 is illegally present in rice supplies, and has not undergone meaningful reviews for potential health or environmental impacts, U.S. authorities have failed to recall LL601-contaminated rice supplies or food products.  In contrast, Japan has banned U.S. long-grain rice imports, and the European Union is testing all U.S. rice shipments and rejecting those that contain LL601.  Bayer is now asking USDA to grant retroactive market approval of the illegal rice, even though the company gave up plans to market LL601 in 2001 and it remains untested.

Thursday, February 2, 2012

Waiting for FDA approval: Anti-HIV pill ‘Truvada’ to cause AIDS epidemic?


It has been proven to drastically decrease the chances of contracting HIV before one is even exposed to the virus: Truvada is considered a medical breakthrough by some, yet others fear the once-a-day prevention pill could spur a deadly AIDS epidemic.

Tenofovir is a drug also used with another drug called Emtricitabine marketed as Emtriva, made by Gilead Drug Company. Tenofovir was approved by the FDA in 2001, as a treatment for HIV. and in 2008 for hepatitis.  The most common side effects is nausea, diarrhea, and can cause acute kidney failure, or tubular necrosis.
Studies and sample studies are small and tests by Family Health International warn about formulating any conclusive evidence that Tenofovir works to reduce the rate of HIV infection.
Emtricitabine causes abnormal skin color changes and sensation, depression, diarrhea, changes in color of the palms of the hands or skin on the soles of the feet,and many more including lack of energy.  More severe allergic reactions including swelling of the mouth, tongue, face, lips, fever, stomach aches, yellowing of eyes/skin, and rashes.  Nervous disorders are a side effect of this drug, including nerve damage (neuropathy) depression, paresthesia a numbing, tingling  or loss of sensation.
Costs of the Drug:  $ 8,000.00 a year per person.
The drug — a small, blue pill ingested orally — is currently awaiting FDA approval. Its manufacturer, Gilead, argues that Truvada would reduce the risk of risk of contracting HIV in as many as three-quarters of cases and has been proven so in tests already. AIDS Healthcare Foundation President Michael Weinstein is weary of how people will use the pill, however, and warns, “I believe that this could be catastrophic in terms of HIV prevention.”
The argument against approving the pill, says Weinstein, is that it will encourage partners to engage in unprotected sex. While the pill is proven to work in many cases, it is not 100-percent guaranteed. The result, he says, could only make things worse for AIDS and HIV.
It’s a “fabulous drug – it’s one pill once a day, and it has a low side-effect burden,” says Weinstein. Unless the user is aware that the success rate of Truvada is limited and takes extra precautions such as traditional prophylactics though, that ignorance might trigger an AIDS epidemic that could destroy America.more 

Wednesday, February 1, 2012

Antibiotic-Resistant Bacteria Found in 37 U.S. States, as Congress wants to limit public research in science with HR3699(another form of SOPA).


Half a world away, doctors in India are fighting outbreaks of bacterial infections that are resistant to more than 15 types of antibiotics. But closer to home, a similarly scary bug is making the rounds in intensive care and other long-term units of American hospitals.

India Finds Cases Of Tuberculosis Completely Resistant To Drugs

This is scary.
A report  out of India identifies four new cases of tuberculosis that are completely resistant to drug treatment. They gave all four patients, ages ranging from 20 to 57, the full first-line and second-line batteries of drugs. The first-line included four to five drugs and the second-line five to six drugs for the patients. The drugs had no effect.
In at least 37 states, Washington, D.C., and Puerto Rico, doctors have identified bacteria, including E. coli, that produce Klebsiella pneumoniae carbapenemase, or KPC–an enzyme that makesbacteria resistant to most known treatments. It’s much more prevalent in America than bacteria that produce NDM-1, the enzyme that has Indian doctors ”hell scared,” and, according toAlexander Kallen, a medical officer at the Centers for Disease Control in Atlanta, the final outcome isn’t much different: superbacteria that are hard to kill.
That’s bad news for infected patients–the mortality rate for patients infected with KPC-producing bacteria has been estimated to be as high as 50 percent. Doctors are advised to do their best to keep the bacteria from spreading, which explains why the problem is most prevalent in hospitals and other close-quarter medical units. Infected patients are often isolated.
KPC has been seen in a wide range of bacteria, including E. coli, Salmonella, and K. pneumonia, which often affects hospitalized patients.

These superbugs are resistant to nearly every weapon doctors can throw at them, including carbapenems, a class of antibiotic that the CDC calls the “last line of defense” against infections that are resistant to other types of antibiotics.
CDC researchers, including Kallen, say that hospitals who haven’t been vigilant about isolating patients with KPC-producing bacteria may have missed their chance. According to a paper co-authored by Kallen released last year, “failure to recognize CRE infections when they first occur in a facility has resulted in a missed opportunity to intervene before these organisms are transmitted more widely.”More    thank you battleskin88

No Science for You!

Congress wants to limit your access to research—even though your tax dollars paid for it. If this bill passes, you’ll learn only what mainstream medicine wishes you to know.Action Alert!
In 2008, the National Institutes of Health required that all federally funded research publications be made openly available. PubMedCentral (PMC) is a free full-text archive of biomedical and life sciences journal literature at the National Institutes of Health’s National Library of Medicine.
The publishers of the journals weren’t so happy with this new arrangement—they were afraid no one would pay for their publications if the research results were immediately accessible. So the government agreed to give them a full year of journal sales before their research papers had to be posted on PMC, which lets them keep their subscriber base. Journal subscriptions to educational and medical institutions are expensive—and they’re big business.
But even this generous arrangement isn’t good enough for the Association of American Publishers (AAP). The trade group liked the old rules, where they could sell the tax-funded research back to the taxpayers. So the AAP got two members of Congress, Rep. Carolyn Maloney (D-NY) and Rep. Darrell Issa (R-CA), to introduce HR 3699, the Research Works Act, just before the end of 2011.
This bill would prevent the NIH or any other agency from causing or even allowing private-sector research work to be disseminated online without prior consent of both the publisher and the study authors—even if the funding came from our tax dollars.
So what can you do? Two things will make a huge difference!

  • First, help us gain co-sponsors for the Free Speech about Science Act (FSAS). This landmark legislation enables the natural health products community to share peer-reviewed scientific findings about natural health products with the public. The problem, of course, is that if it becomes more difficult for supplement companies and consumers to access the scientific studies themselves, the entire point of FSAS is effectively undermined.
  • The second step is to ask Congress to defeat this new Research Works Act. Please send your message today and explain why limiting access to the results of important studies—which your tax dollars have already paid for—is such a terrible idea. Take action immediately!

How’s this for evil! FDA’s New Claim: “Your Body Is a Drug—and We Have the Authority to Regulate It!”


This time the FDA just nakedly says in court documents that the agency wants to protect the market for FDA-approved drugs. 
In another outrageous power-grab, FDA says your own stem cells are drugs—and stem cell therapy is interstate commerce because it affects the bottom line of FDA-approved drugs in other states!

We wish this were a joke, but it’s the US Food and Drug Administration’s latest claim in its battle with a Colorado clinic over its Regenexx-SD™ procedure, a non-surgical treatment for people suffering from moderate to severe joint or bone pain using adult stem cells.

The FDA asserts in a court document that it has the right to regulate the Centeno-Schultz Clinic for two reasons:

  1. Stem cells are drugs and therefore fall within their jurisdiction. (The clinic argues that stem cell therapy is the practice of medicine and is therefore not within the FDA’s jurisdiction!)
  2. The clinic is engaging in interstate commerce and is therefore subject to FDA regulation because any part of the machine or procedure that originates outside Colorado becomes interstate commerce once it enters the state. Moreover, interstate commerce is substantially affected because individuals traveling to Colorado to have the Regenexx procedure would “depress the market for out-of-state drugs that are approved by FDA .”

We discussed the very ambiguous issue of interstate commerce last September—it’s an argument the FDA frequently uses when the basis for their claim is otherwise lacking. As we noted then, the FDA holds that an “interstate commerce” test must be applied to all steps in a product’s manufacture, packaging, and distribution. This means that if any ingredient or tool used in the procedure in question was purchased out of state, the FDA would in its view have jurisdiction, just as they would if the final product had traveled across state lines.more
thank you Steve and Stacie

This is what a Gangster Look Like! Now Pull Up Your PANTS YOU ARE NOT A GANGSTER